NLRP3 and Hutchinson-Gilford progeria syndrome: However, most of the drugs trialed to treat HGPS, such as metformin, resveratrol, rapamycin, quercetin, or spermidine, only indirectly inhibit inflammatory pathways, including the NLRP3 inflammasome (Cordero et al., 2018).